BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33778002)

  • 1. Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
    Long G; Ouyang W; Zhang Y; Sun G; Gan J; Hu Z; Li H
    Front Mol Biosci; 2021; 8():608369. PubMed ID: 33778002
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
    Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
    Front Surg; 2021; 8():665115. PubMed ID: 34136527
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
    Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
    Front Genet; 2021; 12():778503. PubMed ID: 35111198
    [No Abstract]   [Full Text] [Related]  

  • 6. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
    Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
    J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
    Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
    Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
    Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
    Front Genet; 2020; 11():586376. PubMed ID: 33329725
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel 13 RNA binding proteins (RBPs) signature could predict prostate cancer biochemical recurrence.
    Xing Q; Liu S; Luan J; Wang Y; Ma L
    Pathol Res Pract; 2021 Sep; 225():153587. PubMed ID: 34419719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 8-gene panel for prediction of early biochemical recurrence in patients with prostate cancer after radical prostatectomy.
    Guo J; Zhao C; Zhang X; Wan Z; Chen T; Miao J; Cai J; Xie W; Chen H; Huang M; Zhao X; Wei W; Shen Q
    Am J Cancer Res; 2022; 12(7):3318-3332. PubMed ID: 35968320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 15-Gene Signature and Prognostic Nomogram for Predicting Overall Survival in Non-Distant Metastatic Oral Tongue Squamous Cell Carcinoma.
    Liu M; Tong L; Liang B; Song X; Xie L; Peng H; Huang D
    Front Oncol; 2021; 11():587548. PubMed ID: 33767977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
    Wu X; Lv D; Eftekhar M; Khan A; Cai C; Zhao Z; Gu D; Liu Y
    Transl Androl Urol; 2020 Dec; 9(6):2572-2586. PubMed ID: 33457230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of cancer-associated fibroblast-related subtypes and the prognosis model of biochemical recurrence in prostate cancer based on single-cell and bulk RNA sequencing.
    Li T; Zhou Z; Xie Z; Fan X; Zhang Y; Zhang Y; Song X; Ruan Y
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11379-11395. PubMed ID: 37369799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer.
    Yang C; Chen L; Niu Q; Ge Q; Zhang J; Tao J; Zhou J; Liang C
    Cancer Cell Int; 2022 Dec; 22(1):382. PubMed ID: 36471446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.
    Yu Z; Chao H; Xu F; Deng H; Deng L; Song Z; Zeng T
    Front Oncol; 2023; 13():1115718. PubMed ID: 37077837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of lncRNAs-based nomogram for prediction of biochemical recurrence in prostate cancer by bioinformatics analysis.
    Shao N; Tang H; Qu Y; Wan F; Ye D
    J Cancer; 2019; 10(13):2927-2934. PubMed ID: 31281469
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
    Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
    Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a Novel Combined Nomogram for Predicting the Risk of Progression Related to Castration Resistance in Patients With Prostate Cancer.
    Li S; Shi L; Li F; Yao B; Chang L; Lu H; Song D
    Front Genet; 2022; 13():823716. PubMed ID: 35620461
    [No Abstract]   [Full Text] [Related]  

  • 19. A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma.
    Xu Z; Xu L; Liu L; Li H; Jin J; Peng M; Huang Y; Xiao H; Li Y; Guan H
    Front Oncol; 2021; 11():625452. PubMed ID: 33954109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy.
    Cai Y; Lin J; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
    Front Oncol; 2022; 12():1009921. PubMed ID: 36324578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.